Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; Relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure

HPB Surgery

Volumn 11, Issue 1, 1998, Pages 13-21

  Jenkins, S A ^a   Nott, D M ^a   Baxter, J N ^a  

^a MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Octreotide; Pharmacokinetics; Somatostatin; Wedged hepatic venous pressure

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HEMODYNAMICS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031770202     PISSN: 08948569     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/17436     Document Type: Article

References (27)